Adaptive Biotechnologies Corporation

1551 Eastlake Avenue East
Suite 200
Seattle,  WA  98102

United States
http://www.adaptivebiotech.com
  • Booth: 1343

Adaptive Biotechnologies is a pioneer and leader in the field of immunosequencing. Adaptive leverages its technology platform to power innovative clinical diagnostics, enable groundbreaking research, and drive therapeutic development to improve patient care. Adaptive’s lead clinical diagnostic, the clonoSEQ® Assay, provides standardized, sensitive, and specific assessment of measurable residual disease (MRD) in patients with lymphoid cancers like acute lymphoblastic leukemia and myeloma.

 

Have a Question?
Call 888-273-5704

International callers dial
001 703-449-6418

Monday - Friday
9 a.m. - 5 p.m.
Eastern Time

Contact us
    • ASH Exposition Management
    • SPARGO, Inc.
    • Toll Free: (800) 564-4220
    • Phone: (703) 631-6200
    • Fax: (703) 563-2691
    • Email: ashexhibits@spargoinc.com